BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6197736)

  • 1. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors.
    Holder IA
    Rev Infect Dis; 1983; 5 Suppl 5():S914-21. PubMed ID: 6197736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.
    Holder IA; Haidaris CG
    Can J Microbiol; 1979 May; 25(5):593-9. PubMed ID: 89891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease.
    Holder IA; Wheeler R
    Can J Microbiol; 1984 Sep; 30(9):1118-24. PubMed ID: 6439405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes.
    Neely AN; Law EJ; Holder IA
    Infect Immun; 1986 Apr; 52(1):200-4. PubMed ID: 2420722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
    Holder IA; Wheeler R; Montie TC
    Infect Immun; 1982 Jan; 35(1):276-80. PubMed ID: 6797948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model.
    Döring G; Dalhoff A; Vogel O; Brunner H; Dröge U; Botzenhart K
    J Infect Dis; 1984 Apr; 149(4):532-7. PubMed ID: 6427361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of exotoxin A to purified Pseudomonas proteolytic enzymes.
    Jagger K; Nickol MM; Saelinger CB
    Infect Immun; 1980 Jun; 28(3):746-52. PubMed ID: 6156907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa elastase and its role in pseudomonas infections.
    Wretlind B; Pavlovskis OR
    Rev Infect Dis; 1983; 5 Suppl 5():S998-1004. PubMed ID: 6419322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.
    Snell K; Holder IA; Leppla SA; Saelinger CB
    Infect Immun; 1978 Mar; 19(3):839-45. PubMed ID: 417031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.
    Pavlovskis OR; Wretlind B
    Infect Immun; 1979 Apr; 24(1):181-7. PubMed ID: 110690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA; Naglich JG
    Am J Med; 1984 Mar; 76(3A):161-7. PubMed ID: 6424445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
    Brodinova NS; Moroz AF; Luchina TYa
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].
    Döring G; Obernesser HJ; Botzenhart K
    Zentralbl Bakteriol A; 1981 Mar; 249(1):89-98. PubMed ID: 6791405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of Pseudomonas aeruginosa Infection by Propeptide-Mediated Inhibition of Protease IV.
    Kim TH; Li XH; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0078221. PubMed ID: 34704789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phosphoramidon on protection against corneal ulcer caused by elastase and protease from Pseudomonas aeruginosa.
    Kawaharajo K; Homma JY; Aoyagi T; Umezawa H
    Jpn J Exp Med; 1982 Oct; 52(5):271-2. PubMed ID: 6820397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.